Healthcare utilization by women in a comprehensive managed care population subsequent to diagnosis of a sexually transmitted disease

Sexually Transmitted Diseases

Volumn 29, Issue 11, 2002, Pages 678-688

  Wilson, Sandra R ^a,b,f   Brown, Nancy L ^a,f   Leyden, Wendy A ^c,f   Manos, M Michele ^c,f   Chin, Victor ^d,f   Levin, David ^d,f   Braverman, Paula ^e,f   Shapiro, Stanley ^f   Lavori, Philip W ^b,f  

^a PALO ALTO MEDICAL FOUNDATION RESEARCH INSTITUTE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DIVISION OF RESEARCH   (United States)

^d KAISER PERMANENTE MEDICAL CENTER   (United States)

^e ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

^f KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BEHAVIOR DISORDER; BLEEDING; CANDIDIASIS; ECTOPIC PREGNANCY; ENDOMETRITIS; FEMALE; GYNECOLOGY; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MANAGED CARE; MENSTRUATION DISORDER; MENTAL HEALTH; OBSTETRICS; PELVIC INFLAMMATORY DISEASE; PREGNANCY COMPLICATION; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX DYSPLASIA; VAGINITIS;

EID: 0036843333     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-200211000-00011     Document Type: Article

References (17)

1. Institute of Medicine. The Hidden Epidemic: Confronting Sexually Transmitted Diseases. Washington, DC: National Academy Press, 1997:1-54.
2. Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996; 334:1399-1401.
3. Cates W, Wasserheit JN, Marchbanks PA. Pelvic inflammatory disease and tubal infertility: The preventable conditions. Ann NY Acad Sci 1994; 709:178-194.
4. Wasserheit JN. HIV infection and other STDs: So close and yet so far. Sex Transm Dis 1999; 26:549-550.
5. Centers for Disease Control and Prevention. HIV prevention through early detection and treatment of other sexually transmitted diseases: United States. Recommendations of the Advisory Committee for HIV and STD Prevention. MMWR Morb Mortal Wkly Rep 1998; 47(RR-12):1-24.
6. Cates W Jr, Rolfs RT Jr, Aral SO. Sexually transmitted diseases, pelvic inflammatory disease, and infertility: An epidemiologic update. Epidemiol Rev 1990; 12:199-220.
7. Centers for Disease Control and Prevention, Division of STD Prevention. 1999 Sexually Transmitted Disease Surveillance Report. Atlanta: Department of Health and Human Services, September 2000. Available at: http://www.cdc.gov/nchstp/dstd/Stats_Trends/1999SurvRpt.htm.
8. Cates W Jr, Wasserheit JN. Genital chlamydial infections: Epidemiology and reproductive sequelae. Am J Obstet Gynecol 1991; 164:1771-1781.
9. Haddix AC, Hillis SD, Kassler WJ. The cost effectiveness of azithromycin for Chlamydia trachomatis infections in women. Sex Transm Dis 1995; 22:274-280.
10. Marrazzo JM, Celum CL, Hillis SD, Fine D, Delisle S, Handsfield HH. Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women: Implications for a national chlamydia control strategy. Sex Transm Dis 1997; 24:131-141.
11. Weström L, Joesoef R, Reynolds G, Hadgu A, Thompson SE. Pelvic inflammatory disease and fertility: A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 1992; 19:185-192.
12. Hillis SD, Joesoef R, Marchbanks PA, Wasserheit JN, Cates W Jr, Weström L. Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility. Am J Obstet Gynecol 1993:168:1503-1509.
13. Expert Committee on Pelvic Inflammatory Disease. Pelvic inflammatory disease: Research directions in the 1990s. Sex Transm Dis 1991; 18:46-64.
14. SAS/STAT User's Guide: Version 6. 4th Ed. Cary, North Carolina: SAS Institute, 1990.
15. Stergachis A, Scholes D, Heidrich FE, Sherer DM, Holmes KK, Stamm WE. Selective screening for Chlamydia trachomatis infection in a primary care population of women. Am J Epidemiol 1993; 138:143-153.
16. Howell MR, Quinn TC, Gaydos CA. Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics: A cost-effectiveness analysis of three strategies. Ann Intern Med 1998; 128:277-284.
17. US Preventive Services Task Force Calls for Chlamydia, Lipid Screening Among First Four Recommendations [press release]. Rockville, Maryland: Agency for Healthcare Research and Quality. April 17, 2001. Available at: http://www.ahrq.gov/news/press/pr2001/lipidpr.htm.